Tag: Personalized Genomics Market Growth

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Personalized Genomics Market CAGR Outlook And Future Development

The market size for personalized genomics has experienced rapid growth in recent years. It will grow from $9.45 billion in 2025 to $10.96 billion in 2026 at a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to factors such as the decreasing costs of genetic sequencing, the rising prevalence of chronic and genetic diseases, an increase in research-based genomics studies, the expansion of diagnostic laboratory infrastructure, and the early adoption of precision medicine approaches.

The personalized genomics market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $19.61 billion in 2030, showing a compound annual growth rate (CAGR) of 15.7%. This expansion during the forecast period is attributable to the incorporation of genomics into routine clinical practice, a rising demand for personalized medicine, continuous advancements in sequencing technologies, the broadening of wellness and ancestry testing, and increasing investments from pharmaceutical and biotechnology companies. Significant trends expected during this period include an increase in the adoption of direct-to-consumer genetic testing, a growing application of pharmacogenomics in treatment planning, an escalating demand for preventive and predictive healthcare solutions, the expansion of genetic testing within reproductive health, and enhanced consumer awareness regarding lifestyle and wellness genomics.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=10045290&type=smp&name=Personalized%20Genomics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Personalized Genomics Market Demand Drivers Opening New Revenue Streams

The increasing incidence of chronic illnesses is anticipated to boost the expansion of the personalized genomics market in the future. These enduring health conditions necessitate continuous care and include ailments such as diabetes, cardiac disease, high blood pressure, and various intricate health challenges. The surge in chronic ailments is primarily attributable to an aging populace, inactive lifestyles, inadequate nutrition, and environmental elements fostering the simultaneous emergence of multiple health problems. Personalized genomics aids in managing chronic conditions by facilitating extensive genotyping and sequencing, which helps categorize patients based on genetic risk, thereby enabling more accurate diagnoses, tailored treatments, and improved preventive measures. As an illustration, in April 2025, data from the U.S. Centers for Disease Control and Prevention (CDC), an US-based organization, indicated that 76.4% of U.S. adults, approximately 194 million individuals, were living with at least one of 12 specific chronic conditions, with 51.4% (around 130 million) affected by two or more. Consequently, the growing prevalence of chronic illnesses is serving as a catalyst for the expansion of the personalized genomics market.

Personalized Genomics Market Segment Outlook: Which Categories Are Growing Fastest?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

Personalized Genomics Market Trends Powering Strategic Industry Growth

Leading firms within the personalized genomics market are concentrating on creating advanced technologies, such as personalized genomics platforms, designed to offer customized understanding of health, well-being, and strategies for preventing illnesses. Such a platform functions by examining an individual’s genetic information to provide bespoke insights and advice concerning their health, overall well-being, and susceptibility to diseases. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, unveiled Geniee Decode Your DNA, a novel customized genomics platform. This specific personalized genomics platform delivers tailored insights on health, nutritional needs, and medication responses, all derived from an individual’s genetic makeup, with the goal of optimizing wellness, aiding in disease prevention, and facilitating personalized treatments for improved health outcomes.

Personalized Genomics Market Leading Companies And Competitive Benchmarking

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

View The Full Personalized Genomics Market Report:

https://thebusinessresearchcompany.com/report/personalized-genomics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Personalized Genomics Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Personalized Genomics Market Growth Potential: How Will Market Size Change Through 2030?

The personalized genomics market has experienced significant expansion in recent years, with the sector projected to increase from $9.45 billion in 2025 to $10.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.0%. This historical growth has been largely driven by factors such as the decreasing expenses associated with genetic sequencing, a rising incidence of chronic and genetic disorders, enhanced research activities in genomics, the development and broadening of diagnostic laboratory facilities, and the early implementation of precision medicine strategies.

The personalized genomics market is projected to experience rapid expansion over the coming years. By 2030, it is expected to reach $19.61 billion, driven by a compound annual growth rate (CAGR) of 15.7%. Growth during this forecast period is fueled by the integration of genomics into standard clinical practices, an increasing need for tailored medical treatments, improvements in sequencing technologies, the broadening of wellness and ancestry testing services, and heightened investments from pharmaceutical and biotechnology firms. Key trends for this period encompass the growing popularity of direct-to-consumer genetic testing, the wider application of pharmacogenomics in designing treatment plans, a rising emphasis on preventive and predictive healthcare, the expansion of genetic testing within reproductive health, and greater public awareness regarding lifestyle and wellness genomics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Personalized Genomics Market Growth Factors: Which Forces Are Supporting Market Expansion?

The growing incidence of chronic conditions is anticipated to accelerate the expansion of the personalized genomics market moving forward. Chronic diseases are enduring health issues that necessitate ongoing care and include ailments such as diabetes, heart disease, hypertension, and various other complex medical problems. This uptick in chronic illnesses is mainly driven by aging populations, inactive lifestyles, poor eating habits, and environmental influences, which often result in the simultaneous occurrence of multiple conditions. Personalized genomics aids in managing chronic diseases by facilitating large-scale genotyping and sequencing to categorize patients according to genetic susceptibility, thus enabling more accurate diagnostics, targeted therapies, and improved preventive approaches. For example, in April 2025, the U.S. Centers for Disease Control and Prevention (CDC), an American agency, reported that 76.4% of U.S. adults—roughly 194 million individuals—had at least one of twelve specific chronic conditions, and 51.4% (around 130 million) had two or more of these conditions. Consequently, the rising prevalence of chronic diseases is fueling the growth of the personalized genomics market.

Personalized Genomics Market Segmentation And Category Breakdown

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

Personalized Genomics Market Industry Trends: What Changes Are Reshaping Demand?

Leading industry players in the personalized genomics sector are prioritizing the development of advanced technologies, including personalized genomics platforms, designed to deliver customized insights into health, wellness, and disease avoidance. A personalized genomics platform functions by examining an individual’s genetic information to produce specific recommendations and perspectives concerning health, well-being, and illness susceptibility. As an example, in September 2024, Neuberg Diagnostics Private Limited, a diagnostic service provider headquartered in India, launched Geniee Decode Your DNA, an innovative personalized genomics platform. This system offers individualized guidance on health, nutrition, and medication derived from your genetic profile, aiding in the optimization of wellness, the prevention of diseases, and the customization of treatments for superior health outcomes.

Personalized Genomics Market Competitive Analysis Of Major Industry Participants

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Access The Complete Personalized Genomics Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Personalized Genomics Market Geographic Distribution And Regional Opportunities

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Personalized Genomics Market By 2030?

The personalized genomics market has experienced significant expansion recently. Projections indicate its value will rise from $9.45 billion in 2025 to $10.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.0%. Historically, this expansion has been driven by factors such as the decreasing expenses associated with genetic sequencing, the rising incidence of both chronic and genetic conditions, an increase in genomics research, the development of diagnostic laboratory facilities, and the early embrace of precision medicine strategies.

The personalized genomics market is projected to experience substantial expansion over the coming years, with its size forecast to reach $19.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.7%. This growth during the projection period can be attributed to several factors, including the integration of genomics into routine clinical practice, a rising demand for personalized medicine, advancements in sequencing technologies, the expansion of wellness and ancestry testing, and growing investments by pharmaceutical and biotechnology companies. Key trends anticipated for the forecast timeframe encompass the increasing adoption of direct-to-consumer genetic testing, the growing use of pharmacogenomics in treatment planning, a heightened demand for preventive and predictive healthcare, the wider availability of genetic testing in reproductive health, and a rising consumer awareness of lifestyle and wellness genomics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

Which Growth Factors Are Strengthening The Personalized Genomics Market Landscape?

An increasing incidence of chronic illnesses is anticipated to drive the expansion of the personalized genomics market in the future. These are enduring health conditions necessitating continuous care, encompassing ailments such as diabetes, cardiovascular disease, high blood pressure, and various other intricate health concerns. This surge in chronic ailments primarily stems from an aging populace, inactive lifestyles, inadequate nutrition, and environmental elements that collectively foster the concurrent onset of several conditions. Personalized genomics aids in managing chronic conditions by facilitating extensive genotyping and sequencing, which helps categorize patients based on genetic risk, thereby enabling more accurate diagnoses, focused treatments, and enhanced preventive measures. As an illustration, in April 2025, data from the U.S. Centers for Disease Control and Prevention (CDC), a US-based entity, indicated that 76.4% of U.S. adults, totaling approximately 194 million individuals, were afflicted with at least one of 12 specified chronic conditions, while 51.4% (roughly 130 million) suffered from two or more such conditions. Consequently, the growing occurrence of chronic illnesses is propelling the expansion of the personalized genomics market.

How Are Different Segment Groups Identified Within The Personalized Genomics Market?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

Which Trends Are Contributing To Changes In The Personalized Genomics Market?

Leading companies in the personalized genomics market are concentrating on developing innovative technologies, such as personalized genomics platforms, to offer customized insights into health, well-being, and disease prevention. A personalized genomics platform is a system designed to analyze an individual’s genetic information, thereby providing bespoke insights and recommendations related to health, overall wellness, and disease risk. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, introduced Geniee Decode Your DNA, a new customized genomics platform. This platform delivers tailored health, nutrition, and medication insights based on one’s genetic profile. It aims to optimize wellness, prevent diseases, and personalize treatments for improved health outcomes.

Who Are The Businesses Driving Activity In The Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Access The Complete Personalized Genomics Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

What Is The Largest Regional Market In The Personalized Genomics Market?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Personalized Genomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Personalized Genomics Market Between 2026 And 2030?

The personalized genomics market size has experienced rapid expansion in recent years. This market is expected to grow from $9.45 billion in 2025 to $10.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. Historically, the market’s expansion has been fueled by factors such as the decreasing costs of genetic sequencing, the increasing occurrence of chronic and genetic diseases, the rise in research-based genomics studies, the development of diagnostic laboratory infrastructure, and the early adoption of precision medicine approaches.

The personalized genomics market is anticipated to experience significant expansion over the coming years. By 2030, this market is projected to reach $19.61 billion, demonstrating a compound annual growth rate (CAGR) of 15.7%. Several factors contribute to this projected growth, including the integration of genomics into routine clinical practice, increasing demand for personalized medicine, progress in sequencing technologies, the expansion of wellness and ancestry testing, and greater investments from pharmaceutical and biotechnology companies. Key trends anticipated during the forecast period involve the rising adoption of direct-to-consumer genetic testing, the growing use of pharmacogenomics in treatment planning, an increasing need for preventive and predictive healthcare, the broadening of genetic testing in reproductive health, and heightened consumer awareness regarding lifestyle and wellness genomics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Major Factors Are Driving The Personalized Genomics Market Forward?

The increasing incidence of long-term illnesses is projected to stimulate the expansion of the personalized genomics market in the future. These enduring conditions necessitate continuous care and encompass ailments such as diabetes, cardiac disease, high blood pressure, and various intricate health challenges. The surge in chronic diseases is predominantly attributed to an aging demographic, inactive living habits, inadequate nutrition, and environmental elements, all of which foster the simultaneous emergence of numerous health problems. Personalized genomics aids in managing chronic illnesses by facilitating extensive genotyping and sequencing, which helps categorize patients based on their genetic risk, thereby enabling more accurate diagnoses, focused treatments, and improved preventative approaches. As an illustration, data from April 2025, provided by the U.S. Centers for Disease Control and Prevention (CDC), an organization based in the US, indicated that 76.4% of American adults, totaling approximately 194 million individuals, were living with at least one of 12 identified chronic conditions, whereas 51.4% (roughly 130 million) experienced two or more of these ailments. Consequently, the escalating occurrence of chronic illnesses is propelling the expansion of the personalized genomics market.

What Are The Different Segment Types In The Personalized Genomics Market Segment Breakdown?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Trends Are Shaping The Future Of The Personalized Genomics Market?

Leading companies within the personalized genomics market are concentrating on developing innovative technologies, particularly personalized genomics platforms, to deliver customized insights regarding health, wellness, and disease prevention. A personalized genomics platform functions as a system that processes an individual’s genetic data to offer bespoke insights and recommendations related to health, general well-being, and disease risk. For example, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, unveiled Geniee Decode Your DNA, a new customized genomics platform. This platform offers tailored insights into health, nutrition, and medication based on an individual’s genetic profile, thereby assisting in optimizing wellness, preventing illnesses, and personalizing treatments to achieve superior health outcomes.

Who Are The Well-Known Companies In The Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Get The Full Personalized Genomics Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Which Region Has The Greatest Market Share In The Personalized Genomics Market?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Personalized Genomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Personalized Genomics Market Projected To Become By 2030 Based On Its 2026 Valuation?

The personalized genomics market has experienced rapid expansion in recent years. Its value is projected to increase from $9.45 billion in 2025 to $10.96 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to several factors, including the reduction in genetic sequencing costs, the rising incidence of chronic and genetic illnesses, the expansion of research-focused genomics studies, the development of diagnostic laboratory infrastructure, and the early adoption of precision medicine strategies.

The personalized genomics market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $19.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. This growth during the forecast period is primarily driven by the incorporation of genomics into standard clinical practice, an increasing need for personalized medicine, breakthroughs in sequencing technologies, the broadening scope of wellness and ancestry testing, and intensified investments from pharmaceutical and biotechnology firms. Significant trends for the forecast period comprise the increasing uptake of direct-to-consumer genetic testing, the expanding application of pharmacogenomics in planning treatments, a heightened demand for preventive and predictive healthcare, the wider application of genetic testing in reproductive health, and a greater consumer understanding of lifestyle and wellness genomics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Primary Drivers Are Shaping The Development Of The Personalized Genomics Market?

The rising prevalence of chronic diseases is anticipated to drive the expansion of the personalized genomics market. Chronic diseases are persistent conditions that demand continuous management and encompass health issues such as diabetes, heart disease, and hypertension. The increase in these conditions is primarily attributable to an aging population, sedentary lifestyles, poor nutritional habits, and environmental elements that contribute to the simultaneous development of multiple ailments. Personalized genomics assists in managing chronic diseases by enabling extensive genotyping and sequencing, which helps categorize patients by their genetic risk, leading to more precise diagnostics, targeted interventions, and improved prevention strategies. For instance, in April 2025, the U.S. Centers for Disease Control and Prevention (CDC), an US-based organization, reported that 76.4% of U.S. adults, roughly 194 million people, had at least one of 12 specific chronic conditions, while 51.4% (around 130 million) had two or more of these conditions. Thus, the increasing occurrence of chronic diseases is a key driver for the personalized genomics market’s growth.

What Segment Groups Are Identified Within The Personalized Genomics Market?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Trends Are Advancing Progress In The Personalized Genomics Market?

Leading companies in the personalized genomics market are concentrating on developing innovative technologies, such as personalized genomics platforms, to offer customized insights into health, wellness, and disease prevention. A personalized genomics platform constitutes a system that scrutinizes an individual’s genetic data to provide bespoke insights and recommendations pertaining to health, well-being, and susceptibility to illnesses. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service provider, launched Geniee Decode Your DNA, a new customized genomics platform. This platform is a personalized genomics system that provides tailored information on health, nutrition, and medication, all based on one’s genetic profile, thereby aiding in optimizing wellness, preventing diseases, and personalizing treatments for improved health outcomes.

Which Companies Hold Significant Positions In The Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Read the full personalized genomics market report here:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

How Does The Personalized Genomics Market Perform Across Major Global Regions?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Personalized Genomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized genomics market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Personalized Genomics Market in 2030?

The personalized genomics market has seen rapid expansion in recent years. Its value is expected to rise from $9.45 billion in 2025 to $10.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to several factors including the declining costs of genetic sequencing, an increasing prevalence of chronic and genetic diseases, a rise in research-based genomics studies, the expansion of diagnostic laboratory infrastructure, and the early adoption of precision medicine approaches.

The personalized genomics market is poised for substantial expansion in the coming years, with its size projected to reach $19.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. This growth over the forecast period is fueled by several factors, including the integration of genomics into standard clinical practice, a surging demand for personalized medicine, continuous advancements in sequencing technologies, the broadening availability of wellness and ancestry testing, and increasing investments from pharmaceutical and biotechnology companies. Significant trends anticipated during this period include the rising adoption of direct-to-consumer genetic testing, the expanding application of pharmacogenomics in treatment planning, a greater emphasis on preventive and predictive healthcare, the wider use of genetic testing in reproductive health, and enhanced consumer awareness regarding lifestyle and wellness genomics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Drivers Are Influencing Production Trends In The Personalized Genomics Market?

The increasing occurrence of chronic illnesses is anticipated to boost the personalized genomics market in the future. These are enduring health conditions, such as diabetes, heart disease, and high blood pressure, among other intricate health problems, necessitating continuous care. The rise in such diseases is primarily linked to an aging global population, inactive lifestyles, inadequate nutrition, and environmental elements, which together foster the simultaneous emergence of several health conditions. Personalized genomics assists in managing chronic diseases by facilitating extensive genotyping and sequencing, which helps categorize patients based on their genetic risk, leading to more accurate diagnoses, focused treatments, and improved preventive measures. For example, data from April 2025 provided by the U.S. Centers for Disease Control and Prevention (CDC), an organization based in the US, indicated that 76.4% of American adults, roughly 194 million individuals, were affected by at least one of 12 specific chronic conditions, while 51.4% (approximately 130 million) suffered from two or more of these conditions. Consequently, the growing frequency of chronic diseases is fueling the expansion of the personalized genomics market.

Which Segments Are Gaining Traction In The Personalized Genomics Market?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Industry Trends Are Transforming The Personalized Genomics Market?

Leading companies operating in the personalized genomics market are concentrating on developing advanced technologies, such as personalized genomics platforms, to offer customized insights into well-being, health, and disease prevention. A personalized genomics platform is a system designed to analyze an individual’s genetic data, thereby providing tailored insights and recommendations concerning health, wellness, and the likelihood of disease. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, introduced Geniee Decode Your DNA, which is a new customized genomics platform. This platform delivers personalized insights on health, nutrition, and medication based on an individual’s genetic profile, helping to optimize wellness, prevent diseases, and tailor treatments for improved health outcomes.

Who Are The Top-Performing Companies In The Personalized Genomics Market In Recent Years?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Which Region Currently Holds The Largest Share Of The Personalized Genomics Market?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Genomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Personalized Genomics Industry?

The market size for personalized genomics has expanded swiftly over the past few years. The projected growth is from $8.15 billion in 2024 to a whopping $9.45 billion in 2025, experiencing a compound annual growth rate (CAGR) of 16.0%. This growth during the historical period can be credited to the heightened awareness of genetic risk elements in the general public, an increased incidence of chronic and hereditary illnesses, the progressive incorporation of AI and machine learning in genomic research, the rising interest in nutrigenomics and genomics based on lifestyle, and the escalating emphasis on companion diagnostics concerning oncology and rare diseases.

The market for personalized genomics is set to witness a massive upswing in the near future, with forecasts predicting a growth to $16.97 billion by 2029, growing at a CAGR of 15.8%. This anticipated growth during the forecast period can be traced back to the rising demand for personalized medicine, increasing consumer inclination towards DTC genetic testing, a surge in the adoption of preventive healthcare strategies, easier access to genomic data and bioinformatics tools, and a rise in partnerships between pharmaceutical and genomics firms. Key trends anticipated in the forecasted period include progress in NGS technologies, the utilization of AI in interpreting genomic data, the merging of genomics with electronic health records, advancements in the bioinformatics platform, and emergence of cloud-based genomic data storage and sharing systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Forces Are Driving The Growth Of The Personalized Genomics Industry?

The surge in chronic and rare diseases is anticipated to stimulate expansion in the personalized genomics market. Chronic diseases necessitate persistent management due to their enduring nature, whereas rare diseases, affecting only a minuscule segment of the population, often demand specific healthcare. A number of lifestyle elements like inadequate diet, sedentary behavior, and exposure to environmental risk factors are responsible for the increment in these diseases. Personalized genomics can enable precise disease diagnosis, formulate superior-targeted therapies, and enhance the management of conditions linked to specific genetic causes or risk factors by customizing treatments according to a person’s genetic profile. For example, the National Center for Biotechnology Information, a medical library based in the U.S, revealed that in January 2023, the count of individuals with at least one chronic disease is projected to surge by 99.5%, skyrocketing from 71.522 million in 2020 to 142.66 million by 2050. Therefore, this increase in chronic and rare diseases is a key driver in the growth of personalized genomics market.

What Is The Overview Of Market Segmentation In The Personalized Genomics Industry?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Infectious Disease Testing: Hepatitis Testing, COVID-19 Testing, Respiratory Infections Testing, Sexually Transmitted Infections Testing

3) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

4) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Lipid Panel Testing, Coronary Artery Disease Testing

5) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Paternity Testing, Ancestry Testing

What Future Market Trends Are Projected For The Personalized Genomics Industry?

Leading businesses within the personalized genomics market are concentrating on the advancement of novel technologies, specifically personalized genomics systems, aiming to present bespoke insights into overall health, wellness, and the prevention of diseases. These platforms examine an individual’s genetic information to provide bespoke insights and advice regarding wellness, health, and disease susceptibility. A demonstration of this is the launch of Geniee Decode Your DNA, a bespoke genomics platform by Neuberg Diagnostics Private Limited, an India-based diagnostic service provider, in September 2024. This personalized genomics platform presents custom-made health, nutrition, and medication insights stemming from your genetic composition. Its function is to optimize wellness, aid in the prevention of diseases, and personalize medical treatments to enhance health results.

Who Are The Primary Players Operating Across The Global Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Which Region Offers The Most Growth Potential For The Personalized Genomics Market Through 2029?

North America was the largest region in the personalized genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Personalized Genomics Market Grown from 2024 to 2025?

In the recent past, the market size for personalized genomics has seen a significant rise. It is projected to escalate from $8.15 billion in 2024 to $9.45 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.0%. This remarkable growth during the historical period can be credited to the increased awareness about genetic risk elements among the public at large, the escalating incidence of chronic and genetic illnesses, the expanding incorporation of AI and machine learning in genomic study, the surging demand for nutrigenomics and genomics centered on lifestyle, along with an increasing emphasis on companion diagnostics in the fields of oncology and rare diseases.

What Growth Rate Is Anticipated for the Personalized Genomics Market in the Coming Years?

The size of the personalized genomics market is predicted to expand at a quick pace in the following years. By 2029, it is projected to reach $16.97 billion, with a compound annual growth rate (CAGR) of 15.8%. The forecast period expansion is due to an increased demand for tailor-made medicine, higher consumer interest in direct-to-consumer genetic testing, a rising trend towards preventative health methods, growing access to genomic data and bioinformatics tools, as well as a surge in partnerships between pharmaceutical and genomics companies. The key trends for the projection period consist of advancements in next-generation sequencing technologies, incorporating artificial intelligence in genomic data interpretation, combining genomics with electronic health records, improvements in bioinformatics platforms, and creating cloud-centric systems for storing and sharing genomic data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

Who Are the Leading Companies in the Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

What Are the Key Drivers of the Personalized Genomics Market?

The growth of the personalized genomics market is anticipated to be driven by the increasing prevalence of chronic and rare diseases. Chronic diseases necessitate continuous management because they are enduring conditions, while rare diseases, which affect a small portion of the population and often need specialized care, are less common. The surge in these diseases can also be traced back to lifestyle choices, for example, an unhealthy diet, inadequate exercise, and exposure to harmful environmental factors, which all play a part in the onset of various conditions. Personalized genomics facilitates the management of these diseases by devising treatments based on each person’s genetic profile, which leads to more exact diagnoses, more optimally targeted treatments, and better handling of conditions that may be due to specific genetic factors or risks. For example, the National Center for Biotechnology Information, a US-based medical library, stated in January 2023 that there is projected to be a 99.5% rise in the number of people with at least one chronic disease, increasing from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the increased prevalence of chronic and rare diseases is propelling the growth of the personalized genomics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

What Are the Key Market Segments in the Personalized Genomics Industry?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Infectious Disease Testing: Hepatitis Testing, COVID-19 Testing, Respiratory Infections Testing, Sexually Transmitted Infections Testing

3) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

4) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Lipid Panel Testing, Coronary Artery Disease Testing

5) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Paternity Testing, Ancestry Testing

What Are the Latest Trends in the Personalized Genomics Market?

Leading businesses in the personalized genomics market are concentrating on the advancement of novel technologies such as personalized genomics platforms. These platforms are designed to deliver personalized insights concerning health, wellness, and disease prevention by analysing a person’s genetic data. To illustrate, Neuberg Diagnostics Private Limited, a diagnostic service company based in India, launched a new bespoke genomics platform, Geniee Decode Your DNA, in September 2024. This platform provides customised health, nutrition, and medication advice based on an individual’s genetic make-up. It aims to enhance wellness, avert diseases, and tailor treatments for improved health results.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

What Are the Key Regional Markets in the Personalized Genomics Industry?

North America was the largest region in the personalized genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24654

This Report Delivers Insight On:

1. How big is the personalized genomics market, and how is it changing globally?

2. Who are the major companies in the personalized genomics market, and how are they performing?

3. What are the key opportunities and risks in the personalized genomics market right now?

4. Which products or customer segments are growing the most in the personalized genomics market?

5. What factors are helping or slowing down the growth of the personalized genomics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model